Results 21 to 30 of about 22,252 (260)

Recent Insights into the Paradoxical Effect of Echinocandins

open access: yesJournal of Fungi, 2017
Echinocandin antifungals represent one of the most important drug classes for the treatment of invasive fungal infections. The mode of action of the echinocandins relies on inhibition of the β-1,3-glucan synthase, an enzyme essentially required for the ...
Johannes Wagener, Veronika Loiko
doaj   +2 more sources

Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance? [PDF]

open access: yesmBio
Echinocandins, which target the fungal β-1,3-glucan synthase (Fks), are essential for treating invasive fungal infections, yet resistance is increasingly reported.
Hans Carolus   +13 more
doaj   +2 more sources

Clinical Outcomes of Intra-Abdominal Candidiasis by Initial Antifungal Therapy. [PDF]

open access: yesMycoses
ABSTRACT Background Intra‐abdominal candidiasis (IAC) is a severe and heterogeneous infection associated with significant morbidity and mortality. Objectives To evaluate outcomes of IAC according to initial antifungal therapy and to identify predictors of persistent infection and 30‐day mortality.
Albanell-Fernández M   +6 more
europepmc   +2 more sources

Efficacy and safety of triazoles versus echinocandins in the treatment of invasive aspergillosis: A meta-analysis [PDF]

open access: yesVojnosanitetski Pregled, 2020
Backgroun/Aim. Although majority of guidelines recommend triazoles (voriconazole, posaconazole, itraconazole and isavuconazole) as first-line therapeutic option for treatment of invasive aspergillosis, echinocandins (caspofungin, micafungin and ...
Uzelac Sanja M.   +4 more
doaj   +1 more source

Echinocandins – structure, mechanism of action and use in antifungal therapy

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2022
With increasing number of immunocompromised patients as well as drug resistance in fungi, the risk of fatal fungal infections in humans increases as well.
Mateusz Szymański   +4 more
semanticscholar   +1 more source

Case Report: Echinocandin-Resistance Candida glabrata FKS Mutants From Patient Following Radical Cystoprostatectomy Due to Muscle-Invasive Bladder Cancer

open access: yesFrontiers in Oncology, 2021
Invasive Candida glabrata infections are not common complications after radical cystoprostatectomy. Furthermore, resistance to echinocandins arising during the course of a patient’s treatment is rarely recognised.
Maria Szymankiewicz   +6 more
doaj   +1 more source

The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2020
Invasive fungal infections continue to show steady growth among various patient populations, accompanied by high rates of both morbidity and attributive mortality.
Veselov A.V.
doaj   +1 more source

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

open access: yesMicrobiology spectrum, 2023
The multidrug-resistant Candida auris is a global health emergency, being responsible for outbreaks of invasive candidiasis worldwide. Limited effective therapeutic options make it difficult to treat this emerging pathogen.
Ainara Hernando-Ortiz   +5 more
semanticscholar   +1 more source

Fungal echinocandin resistance [PDF]

open access: yesF1000 Biology Reports, 2010
Echinocandins are the most recent introduction to the antifungal armamentarium and target the synthesis of β-(1,3)-glucan, the major structural polysaccharide of the fungal cell wall. Mechanisms have been identified that reduce the efficacy of the echinocandins: mutations of the Fks subunit of the target enzyme complex or a compensatory increase in the
Walker, Louise A.   +2 more
openaire   +4 more sources

The Epidemiology and Infection Control of Candida Auris in Shanghai. [PDF]

open access: yesMycoses
ABSTRACT Background Candida auris is a globally emerging multidrug‐resistant fungus. Its dissemination is driven by patient movement and asymptomatic carriers. However, molecular epidemiological studies linking imported cases to local strains in large metropolitan areas remain limited.
Wei M   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy